OracleBio will be attending the Pathology Visions 2019 conference, which takes place from the 6th to 8th of October 2019 in Orlando, Florida.
OracleBio will be exhibiting at Booth 318 throughout the meeting.
OracleBio is a highly specialised image analysis CRO (contract research organization) providing high precision, quantitative, digital image analysis services to support pre-clinical and clinical research. Using both Indica Labs HALO™ and Visiopharm Oncotopix® image analysis software platforms we can deliver accurate and detailed quantification of nuclear, membrane and cytoplasmic markers on a cell-by-cell basis within Histology, IHC and ISH tissue sections. The management and employees of the company have over 100 years of combined experience of working within the R&D functions of medium and large Pharma companies and provide the type of high-quality service expected of a specialist image analysis CRO. Click here to find out more information about how our services can support your R&D.
The Pathology Visions 2019 conference will examine the latest advancements in the ever-evolving field of digital pathology and its implications in healthcare, including the clinical and research applications, the regulatory environment, adoption and implementation of digital pathology, validation of digital images and algorithms to name a few. To find out more, please click here.
Lorcan Sherry, Chief Scientific Officer, and Keith Bowers, Senior Business Development Manager, will be in attendance throughout the meeting. If you would like to learn more about OracleBio’s services or arrange a meeting please contact us.
To keep up to date with all OracleBio news and events, follow us on LinkedIn by clicking the button below: